[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Guardant Health Inc (GH)

Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,687,234
  • Shares Outstanding, K 132,573
  • Annual Sales, $ 982,020 K
  • Annual Income, $ -416,280 K
  • EBIT $ -437 M
  • EBITDA $ -403 M
  • 60-Month Beta 1.48
  • Price/Sales 12.46
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 59.45% (-19.24%)
  • Historical Volatility 61.06%
  • IV Percentile 37%
  • IV Rank 33.04%
  • IV High 83.67% on 04/30/26
  • IV Low 47.50% on 08/13/25
  • Expected Move (DTE 5) 6.12 (6.39%)
  • Put/Call Vol Ratio 0.19
  • Today's Volume 1,825
  • Volume Avg (30-Day) 1,461
  • Put/Call OI Ratio 0.64
  • Today's Open Interest 25,290
  • Open Int (30-Day) 22,237
  • Expected Range 89.58 to 101.82

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.75
  • Number of Estimates 3
  • High Estimate $-0.70
  • Low Estimate $-0.78
  • Prior Year $-0.79
  • Growth Rate Est. (year over year) +5.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
74.55 +28.37%
on 04/10/26
98.50 -2.84%
on 05/08/26
+2.86 (+3.08%)
since 04/08/26
3-Month
74.55 +28.37%
on 04/10/26
113.78 -15.89%
on 02/20/26
-6.15 (-6.04%)
since 02/06/26
52-Week
36.36 +163.20%
on 05/23/25
120.74 -20.74%
on 01/22/26
+54.02 (+129.61%)
since 05/08/25

Most Recent Stories

More News
GH Q1 Deep Dive: Shield Volume Acceleration and Oncology Portfolio Expansion Fuel Growth

GH Q1 Deep Dive: Shield Volume Acceleration and Oncology Portfolio Expansion Fuel Growth

GH : 95.70 (+3.73%)
Guardant Health Q1 Earnings Call Highlights

Guardant Health (NASDAQ:GH) reported a strong start to 2026, citing accelerating adoption across its oncology, biopharma and data, and screening businesses as the company delivered $302 million in first-quarter...

GH : 95.70 (+3.73%)
Guardant Health (NASDAQ:GH) Delivers Impressive Q1 CY2026, Stock Soars

Guardant Health (NASDAQ:GH) Delivers Impressive Q1 CY2026, Stock Soars

GH : 95.70 (+3.73%)
Guardant Health: Q1 Earnings Snapshot

Guardant Health: Q1 Earnings Snapshot

GH : 95.70 (+3.73%)
Guardant Health Reports First Quarter 2026 Financial Results and Increases 2026 Revenue Guidance

First quarter 2026 revenue growth of 48% driven by strong performance in Oncology and Screening Raises 2026 revenue guidance to $1.30 to $1.32 billion, representing growth...

GH : 95.70 (+3.73%)
Guardant Health's Path to Profitability Gets Its Latest Cross-Examination Thursday

Barchart Research What to Expect from GH Earnings GH Generated May 6, 2026 Current Price $92.25 EPS Estimate $$-0.71 Consensus Rating Strong Buy Average Move 11.54% Guardant Health's Path to Profitability...

GH : 95.70 (+3.73%)
Guardant Health Earnings: What To Look For From GH

Guardant Health Earnings: What To Look For From GH

GH : 95.70 (+3.73%)
Guardant Health Receives FDA Approval for Guardant360® CDx as a Companion Diagnostic for Arvinas and Pfizer’s VEPPANU (vepdegestrant) for Patients with ER+/HER2- Advanced Breast Cancer with ESR1 Mutations

Blood-based test enables identification of patients eligible for targeted treatment with VEPPANU ™ Approval marks Guardant’s third...

GH : 95.70 (+3.73%)
Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infinityâ„¢ Platform

Multi-year global collaboration will leverage Guardant’s tissue and liquid biopsy portfolio to support clinical development and companion diagnostic strategies

GH : 95.70 (+3.73%)
NUVL : 105.28 (+2.81%)
Guardant Health to Participate in Upcoming Investor Conferences

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences. BofA Securities...

GH : 95.70 (+3.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption,...

See More

Key Turning Points

3rd Resistance Point 109.21
2nd Resistance Point 103.85
1st Resistance Point 99.78
Last Price 95.70
1st Support Level 90.35
2nd Support Level 84.99
3rd Support Level 80.92

See More

52-Week High 120.74
Last Price 95.70
Fibonacci 61.8% 88.51
Fibonacci 50% 78.55
Fibonacci 38.2% 68.59
52-Week Low 36.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.